001     144594
005     20240229112630.0
024 7 _ |a 10.1002/gepi.22242
|2 doi
024 7 _ |a pmid:31407831
|2 pmid
024 7 _ |a 0741-0395
|2 ISSN
024 7 _ |a 1098-2272
|2 ISSN
024 7 _ |a altmetric:64938296
|2 altmetric
037 _ _ |a DKFZ-2019-02036
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Din, Lennox
|b 0
245 _ _ |a Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
260 _ _ |a New York, NY
|c 2019
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1573734277_25202
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Genet Epidemiol. 2019 Oct;43(7):844-863
520 _ _ |a Epidemiologic studies show an increased risk of non-Hodgkin lymphoma (NHL) in patients with autoimmune disease (AD), due to a combination of shared environmental factors and/or genetic factors, or a causative cascade: chronic inflammation/antigen-stimulation in one disease leads to another. Here we assess shared genetic risk in genome-wide-association-studies (GWAS). Secondary analysis of GWAS of NHL subtypes (chronic lymphocytic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, and marginal zone lymphoma) and ADs (rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis). Shared genetic risk was assessed by (a) description of regional genetic of overlap, (b) polygenic risk score (PRS), (c)'diseasome', (d)meta-analysis. Descriptive analysis revealed few shared genetic factors between each AD and each NHL subtype. The PRS of ADs were not increased in NHL patients (nor vice versa). In the diseasome, NHLs shared more genetic etiology with ADs than solid cancers (p = .0041). A meta-analysis (combing AD with NHL) implicated genes of apoptosis and telomere length. This GWAS-based analysis four NHL subtypes and three ADs revealed few weakly-associated shared loci, explaining little total risk. This suggests common genetic variation, as assessed by GWAS in these sample sizes, may not be the primary explanation for the link between these ADs and NHLs.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Sheikh, Mohammad
|b 1
700 1 _ |a Kosaraju, Nikitha
|b 2
700 1 _ |a Smedby, Karin Ekstrom
|b 3
700 1 _ |a Bernatsky, Sasha
|b 4
700 1 _ |a Berndt, Sonja I
|b 5
700 1 _ |a Skibola, Christine F
|b 6
700 1 _ |a Nieters, Alexandra
|b 7
700 1 _ |a Wang, Sophia
|b 8
700 1 _ |a McKay, James D
|b 9
700 1 _ |a Cocco, Pierluigi
|b 10
700 1 _ |a Maynadié, Marc
|b 11
700 1 _ |a Foretová, Lenka
|b 12
700 1 _ |a Staines, Anthony
|b 13
700 1 _ |a Mack, Thomas M
|b 14
700 1 _ |a de Sanjosé, Silvia
|b 15
700 1 _ |a Vyse, Timothy J
|b 16
700 1 _ |a Padyukov, Leonid
|b 17
700 1 _ |a Monnereau, Alain
|b 18
700 1 _ |a Arslan, Alan A
|b 19
700 1 _ |a Moore, Amy
|b 20
700 1 _ |a Brooks-Wilson, Angela R
|b 21
700 1 _ |a Novak, Anne J
|b 22
700 1 _ |a Glimelius, Bengt
|b 23
700 1 _ |a Birmann, Brenda M
|b 24
700 1 _ |a Link, Brian K
|b 25
700 1 _ |a Stewart, Carolyn
|b 26
700 1 _ |a Vajdic, Claire M
|b 27
700 1 _ |a Haioun, Corinne
|b 28
700 1 _ |a Magnani, Corrado
|b 29
700 1 _ |a Conti, David V
|b 30
700 1 _ |a Cox, David G
|b 31
700 1 _ |a Casabonne, Delphine
|b 32
700 1 _ |a Albanes, Demetrius
|b 33
700 1 _ |a Kane, Eleanor
|b 34
700 1 _ |a Roman, Eve
|b 35
700 1 _ |a Muzi, Giacomo
|b 36
700 1 _ |a Salles, Gilles
|b 37
700 1 _ |a Giles, Graham G
|b 38
700 1 _ |a Adami, Hans-Olov
|b 39
700 1 _ |a Ghesquières, Hervé
|b 40
700 1 _ |a De Vivo, Immaculata
|b 41
700 1 _ |a Clavel, Jacqueline
|b 42
700 1 _ |a Cerhan, James R
|0 0000-0002-7482-178X
|b 43
700 1 _ |a Spinelli, John J
|b 44
700 1 _ |a Hofmann, Jonathan
|b 45
700 1 _ |a Vijai, Joseph
|b 46
700 1 _ |a Curtin, Karen
|b 47
700 1 _ |a Costenbader, Karen H
|b 48
700 1 _ |a Onel, Kenan
|b 49
700 1 _ |a Offit, Kenneth
|b 50
700 1 _ |a Teras, Lauren R
|b 51
700 1 _ |a Morton, Lindsay
|b 52
700 1 _ |a Conde, Lucia
|b 53
700 1 _ |a Miligi, Lucia
|b 54
700 1 _ |a Melbye, Mads
|b 55
700 1 _ |a Ennas, Maria Grazia
|b 56
700 1 _ |a Liebow, Mark
|b 57
700 1 _ |a Purdue, Mark P
|b 58
700 1 _ |a Glenn, Martha
|b 59
700 1 _ |a Southey, Melissa C
|b 60
700 1 _ |a Din, Morris
|b 61
700 1 _ |a Rothman, Nathaniel
|b 62
700 1 _ |a Camp, Nicola J
|b 63
700 1 _ |a Wong Doo, Nicole
|b 64
700 1 _ |a Becker, Nikolaus
|0 P:(DE-He78)1573258b58c33f1922ca9719d0c8c4ab
|b 65
|u dkfz
700 1 _ |a Pradhan, Nisha
|b 66
700 1 _ |a Bracci, Paige M
|b 67
700 1 _ |a Boffetta, Paolo
|b 68
700 1 _ |a Vineis, Paolo
|b 69
700 1 _ |a Brennan, Paul
|b 70
700 1 _ |a Kraft, Peter
|b 71
700 1 _ |a Lan, Qing
|b 72
700 1 _ |a Severson, Richard K
|b 73
700 1 _ |a Vermeulen, Roel C H
|b 74
700 1 _ |a Milne, Roger L
|b 75
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 76
|u dkfz
700 1 _ |a Travis, Ruth C
|b 77
700 1 _ |a Weinstein, Stephanie J
|b 78
700 1 _ |a Chanock, Stephen J
|b 79
700 1 _ |a Ansell, Stephen M
|b 80
700 1 _ |a Slager, Susan L
|b 81
700 1 _ |a Zheng, Tongzhang
|b 82
700 1 _ |a Zhang, Yawei
|b 83
700 1 _ |a Benavente, Yolanda
|b 84
700 1 _ |a Taub, Zachary
|b 85
700 1 _ |a Madireddy, Lohith
|b 86
700 1 _ |a Gourraud, Pierre-Antoine
|b 87
700 1 _ |a Oksenberg, Jorge R
|b 88
700 1 _ |a Cozen, Wendy
|b 89
700 1 _ |a Hjalgrim, Henrik
|b 90
700 1 _ |a Khankhanian, Pouya
|0 0000-0001-8075-4176
|b 91
773 _ _ |a 10.1002/gepi.22242
|g p. gepi.22242
|0 PERI:(DE-600)1492643-x
|n 7
|p 844-863
|t Genetic epidemiology
|v 43
|y 2019
|x 1098-2272
909 C O |o oai:inrepo02.dkfz.de:144594
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 65
|6 P:(DE-He78)1573258b58c33f1922ca9719d0c8c4ab
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 76
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2019
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b GENET EPIDEMIOL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l Epidemiologie von Krebserkrankungen
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21